Radiotherapy-induced vitiligo in a patient with breast cancer, a case report

Publication:
Radiotherapy-induced vitiligo in a patient with breast cancer, a case report

dc.contributor.author	Villanueva, Francisco
dc.contributor.author	Jara, Natalia
dc.contributor.author	Darlic, Valentina
dc.date.accessioned	2025-01-22T18:10:22Z
dc.date.available	2025-01-22T18:10:22Z
dc.date.issued	2024
dc.description.abstract	Vitiligo is a disease characterised by the autoimmune destruction of melanocytes, manifesting as depigmentation of the skin. We present the case of a female patient with a history of breast cancer who developed vitiligo in the area of the treatment field 12 months after the end of radiotherapy. It has been reported in the literature that vitiligo can occur in patients with a history of vitiligo after radiotherapy, attributable to the Koebner phenomenon, where some treatments can induce new vitiligo lesions in the patient.
dc.description.version	Versión Publicada
dc.identifier.citation	Villanueva FE, Jara NS, Darlic V. Radiotherapy-induced vitiligo in a patient with breast cancer, a case report. Ecancermedicalscience. 2024 Jun 20;18:1716. doi: 10.3332/ecancer.2024.1716
dc.identifier.doi	https://doi.org/10.3332/ecancer.2024.1716
dc.identifier.uri	https://hdl.handle.net/11447/9698
dc.language.iso	en
dc.subject	Koebner phenomenon
dc.subject	Breast cancer
dc.subject	Melanocyte
dc.subject	Radiotherapy
dc.subject	Vitiligo
dc.title	Radiotherapy-induced vitiligo in a patient with breast cancer, a case report
dc.type	Article
dcterms.accessRights	Acceso Abierto
dcterms.source	ecancer
dspace.entity.type	Publication

Now showing 1 - 1 of 1

Name:: Radiotherapy-induced vitiligo in a patient with breast cancer, a case report.pdf
Size:: 438.99 KB
Format:: Adobe Portable Document Format
Description:: Texto Completo

Now showing 1 - 1 of 1